Advances in Alzheimer's Disease

Vol.5 No.2(2016), Paper ID 67805, 14 pages

DOI:10.4236/aad.2016.52006

 

Computational Analyses of Docosahexaenoic Acid (DHA, C22:6, n-3) with Alzheimer’s Disease-Causing Amyloid Peptide Aβ1-42 Reassures Its Therapeutic Utility

 

Michio Hashimoto, Shahdat Hossain, Kentaro Matsuzaki, Abdullah Al Mamun, Hiroyuki Arai, Osamu Shido

 

Department of Environmental Physiology, Faculty of Medicine, Shimane University, Izumoshi, Japan
Laboratory of Alternative Medicine and Behavioral Neurosciences, Department of Biochemistry and Molecular Biology, Jahangirnagar University, Dhaka, Bangladesh
Department of Environmental Physiology, Faculty of Medicine, Shimane University, Izumoshi, Japan
Department of Environmental Physiology, Faculty of Medicine, Shimane University, Izumoshi, Japan
Department of Geriatrics and Gerontology, Division of Brain Sciences, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Department of Environmental Physiology, Faculty of Medicine, Shimane University, Izumoshi, Japan

 

Copyright © 2016 Michio Hashimoto, Shahdat Hossain, Kentaro Matsuzaki, Abdullah Al Mamun, Hiroyuki Arai, Osamu Shido et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Hashimoto, M. , Hossain, S. , Matsuzaki, K. , Mamun, A. , Arai, H. and Shido, O. (2016) Computational Analyses of Docosahexaenoic Acid (DHA, C22:6, n-3) with Alzheimer’s Disease-Causing Amyloid Peptide Aβ1-42 Reassures Its Therapeutic Utility. Advances in Alzheimer's Disease, 5, 73-86. doi: 10.4236/aad.2016.52006.

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.